• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Savara (SVRA)

Common Shares
Sell: $5.40|Buy: $5.93|Change: 0.43 (-7.23%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Address

6836 Bee Cave Road
Building III, Suite 200
Austin
TX
USA
78746

Telephone

+1 512 6141848

Website

https://www.savarapharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Savara Inc Third Quarter Earnings Results for 20262026-11-12T00:00:00
Savara Inc Second Quarter Earnings Results for 20262026-08-13T00:00:00
Savara Inc Annual General Meeting for 20262026-06-05T15:00:00
Savara Inc First Quarter Earnings Results for 20262026-05-13T00:00:00
Savara Inc Annual Report for 20252026-03-27T00:00:00
Savara Inc Fourth Quarter Earnings Results for 20252026-03-27T00:00:00

Previous key dates

NameKey Date
Savara Inc Annual Report for 20252026-03-27T00:00:00
Savara Inc Fourth Quarter Earnings Results for 20252026-03-27T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-14T20:15:00
Evercore ISI 8th Annual Healthcare Conference2025-12-04T10:00:00
Piper Sandler 37th Annual Healthcare Conference2025-12-02T14:30:00
Jefferies London Healthcare Conference2025-11-19T07:00:00
Savara Inc Third Quarter Earnings Results for 20252025-11-12T00:00:00
Guggenheim 2nd Annual Healthcare Innovation Conference2025-11-10T08:30:00
H.C. Wainwright Global Healthcare Conference2025-09-09T13:00:00
Wells Fargo Securities Healthcare Conference2025-09-03T16:30:00
Savara Inc Second Quarter Earnings Results for 20252025-08-13T00:00:00
Savara Inc Annual General Meeting for 20252025-06-05T15:00:00
Savara Jefferies Global Healthcare Conference 20252025-06-04T09:20:00
H.C. Wainwright & Co. 3rd Annual BioConnect Investor Conference2025-05-20T16:30:00
Savara Inc First Quarter Earnings Results for 20252025-05-13T00:00:00
Citizens Life Sciences Conference2025-05-08T10:30:00
Savara Inc Annual Report for 20242025-03-27T00:00:00
Savara Inc Fourth Quarter Earnings Results for 20242025-03-27T00:00:00
Leerink Global Healthcare Conference2025-03-11T10:40:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.